Skip to main content
Fig. 3 | Gut Pathogens

Fig. 3

From: Impact of azithromycin mass drug administration on the antibiotic-resistant gut microbiome in children: a randomized, controlled trial

Fig. 3

Gut microbial diversity, composition and specific bacteria in children receiving either placebo or azithromycin treatment. a Alpha diversity, determined by Shannon’s H, at 24-month follow-up in children receiving either placebo (blue) or azithromycin (red). b Principal coordinates analysis (PCoA) of Bray-Curtis dissimilarity between children by treatment arm. Axes labels indicate the plotted component and percentage variance explained. c Univariate analysis of bacterial species with increased abundance (linear regression coefficient > 0) or decreased abundance (linear regression coefficient < 0) after azithromycin treatment

Back to article page

Gut Pathogens

ISSN: 1757-4749